Cargando…

On reporting results from randomized controlled trials with recurrent events

BACKGROUND: Evidence-based medicine has been advanced by the use of standards for reporting the design and methodology of randomized controlled trials (RCT). Indeed, without this information it is difficult to assess the quality of evidence from an RCT. Although a variety of statistical methods are...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuramoto, Lisa, Sobolev, Boris G, Donaldson, Meghan G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438437/
https://www.ncbi.nlm.nih.gov/pubmed/18513418
http://dx.doi.org/10.1186/1471-2288-8-35
_version_ 1782156521126232064
author Kuramoto, Lisa
Sobolev, Boris G
Donaldson, Meghan G
author_facet Kuramoto, Lisa
Sobolev, Boris G
Donaldson, Meghan G
author_sort Kuramoto, Lisa
collection PubMed
description BACKGROUND: Evidence-based medicine has been advanced by the use of standards for reporting the design and methodology of randomized controlled trials (RCT). Indeed, without this information it is difficult to assess the quality of evidence from an RCT. Although a variety of statistical methods are available for the analysis of recurrent events, reporting the effect of an intervention on outcomes that recur is an area that remains poorly understood in clinical research. The purpose of this paper is to outline guidelines for reporting results from RCTs where the outcome of interest is a recurrent event. METHODS: We used a simulation study to relate an event process and results from analyses of the gamma-Poisson, independent-increment, conditional, and marginal Cox models. We reviewed the utility of regression models for the rate of a recurrent event by articulating the associated study questions, preenting the risk sets, and interpreting the regression coefficients. RESULTS: Based on a single data set produced by simulation, we reported and contrasted results from statistical methods for evaluating treatment effect from an RCT with a recurrent outcome. We showed that each model has different study questions, assumptions, risk sets, and rate ratio interpretation, and so inferences should consider the appropriateness of the model for the RCT. CONCLUSION: Our guidelines for reporting results from an RCT involving a recurrent event suggest that the study question and the objectives of the trial, such as assessing comparable groups and estimating effect size, should determine the statistical methods. The guidelines should allow clinical researchers to report appropriate measures from an RCT for understanding the effect of intervention on the occurrence of a recurrent event.
format Text
id pubmed-2438437
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24384372008-06-26 On reporting results from randomized controlled trials with recurrent events Kuramoto, Lisa Sobolev, Boris G Donaldson, Meghan G BMC Med Res Methodol Research Article BACKGROUND: Evidence-based medicine has been advanced by the use of standards for reporting the design and methodology of randomized controlled trials (RCT). Indeed, without this information it is difficult to assess the quality of evidence from an RCT. Although a variety of statistical methods are available for the analysis of recurrent events, reporting the effect of an intervention on outcomes that recur is an area that remains poorly understood in clinical research. The purpose of this paper is to outline guidelines for reporting results from RCTs where the outcome of interest is a recurrent event. METHODS: We used a simulation study to relate an event process and results from analyses of the gamma-Poisson, independent-increment, conditional, and marginal Cox models. We reviewed the utility of regression models for the rate of a recurrent event by articulating the associated study questions, preenting the risk sets, and interpreting the regression coefficients. RESULTS: Based on a single data set produced by simulation, we reported and contrasted results from statistical methods for evaluating treatment effect from an RCT with a recurrent outcome. We showed that each model has different study questions, assumptions, risk sets, and rate ratio interpretation, and so inferences should consider the appropriateness of the model for the RCT. CONCLUSION: Our guidelines for reporting results from an RCT involving a recurrent event suggest that the study question and the objectives of the trial, such as assessing comparable groups and estimating effect size, should determine the statistical methods. The guidelines should allow clinical researchers to report appropriate measures from an RCT for understanding the effect of intervention on the occurrence of a recurrent event. BioMed Central 2008-05-30 /pmc/articles/PMC2438437/ /pubmed/18513418 http://dx.doi.org/10.1186/1471-2288-8-35 Text en Copyright © 2008 Kuramoto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kuramoto, Lisa
Sobolev, Boris G
Donaldson, Meghan G
On reporting results from randomized controlled trials with recurrent events
title On reporting results from randomized controlled trials with recurrent events
title_full On reporting results from randomized controlled trials with recurrent events
title_fullStr On reporting results from randomized controlled trials with recurrent events
title_full_unstemmed On reporting results from randomized controlled trials with recurrent events
title_short On reporting results from randomized controlled trials with recurrent events
title_sort on reporting results from randomized controlled trials with recurrent events
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438437/
https://www.ncbi.nlm.nih.gov/pubmed/18513418
http://dx.doi.org/10.1186/1471-2288-8-35
work_keys_str_mv AT kuramotolisa onreportingresultsfromrandomizedcontrolledtrialswithrecurrentevents
AT sobolevborisg onreportingresultsfromrandomizedcontrolledtrialswithrecurrentevents
AT donaldsonmeghang onreportingresultsfromrandomizedcontrolledtrialswithrecurrentevents